Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today ...
Two separate research teams used base editing to make single-nucleotide changes in human embryos this month, targeting genes ...
The artificial intelligence buildout has run headlong into a physical bottleneck: electricity. Data centers are demanding power faster than the grid can add it through traditional fixed infrastructure ...
Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...
UCSF researchers are using tiny "mini-organs" to model disease, personalize treatment, and understand human development. They ...
Open access publishing makes scientific research more accessible to researchers, students, and the general public. Discover ...